Valneva SE (INRLF) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
Valneva SE - American Depositary Shares (VALN)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 18, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Valneva SE ( INRLF ) reported total revenues exceeding 170 million, slightly above 2024 levels, with nearly 160 million in product sales. The company achieved a more than 20% reduction in operating cash burn through disciplined cash management. Valneva SE ( INRLF ) advanced its Lyme disease vaccine program with partner Pfizer, with pivotal phase 3 results anticipated. The company successfully refinanced its debt, enhancing financial flexibility. Valneva SE ( INRLF ) is strategically positioned to become a leading vaccine biotech company, focusing on commercial growth and R&D optimization. Negative Points Total product sales decreased by 3.3% over 2024, primarily due to planned reductions in third-party sales and adverse currency impacts. The company reported an operating loss of
Show less
Read more
Impact Snapshot
Event Time:
VALN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VALN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VALN alerts
High impacting Valneva SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
VALN
News
- Valneva Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Valneva SE (VALN) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Valneva inks licensing deal with Elaris for vaccine technology [Seeking Alpha]Seeking Alpha
- Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program [Yahoo! Finance]Yahoo! Finance
- Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine ProgramPR Newswire
VALN
Sec Filings
- 3/18/26 - Form 6-K
- 3/17/26 - Form 20-F
- 3/10/26 - Form SCHEDULE
- VALN's page on the SEC website